Nephros logo

NephrosNASDAQ: NEPH

Profile

Sector:

Healthcare

Country:

United States

IPO:

21 September 2004

Next earnings report:

30 August 2024

Last dividends:

N/A

Next dividends:

N/A
$22.25 M
-77%vs. 3y high
25%vs. sector
-vs. 3y high
-vs. sector
-67%vs. 3y high
67%vs. sector
-85%vs. 3y high
33%vs. sector

Price

regular market | Mon, 01 Jul 2024 13:30:00 GMT
$2.11-$0.06(-2.76%)

Dividend

No data over the past 3 years
$3.52 M$3.86 M
$3.52 M-$169.00 K

Analysts recommendations

Institutional Ownership

NEPH Latest News

Nephros, Inc. (NEPH) Q3 2023 Earnings Call Transcript
Seeking Alpha10 November 2023 Sentiment: POSITIVE

Nephros, Inc. (NASDAQ:NEPH ) Q3 2023 Earnings Conference Call November 8, 2023 4:30 PM ET Company Participants Kirin Smith - PCG Advisory Robert Banks - CEO Judy Krandel - Chief Financial Officer Andy Astor - Advisor and Interim CFO Conference Call Participants Thomas McGovern - Maxim Group Operator Good afternoon and welcome to the Nephros Inc. Third Quarter 2023 Financial Results Conference Call. All participants will be in listen-only mode.

Nephros to Present at LD Micro Main Event XVI
Newsfile Corp19 September 2023 Sentiment: POSITIVE

South Orange, New Jersey--(Newsfile Corp. - September 19, 2023) - Nephros, Inc. (NASDAQ: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will be presenting at the 16th annual Main Event on Tuesday, October 3rd at 9:00 AM PT at the Luxe Sunset Boulevard Hotel. Robert Banks, President & CEO, will be giving the presentation.

What type of business is Nephros?

Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also develops and sells real-time water testing systems to provide actionable data on waterborne pathogens; and medical device products for patients with renal disease, including a 2nd generation hemodiafiltration system for the treatment of patients with end stage renal disease. In addition, it offers water filters that improve the taste and odor of water, as well as reduce biofilm, bacteria, and scale build-up in downstream equipment under the Nephros and AETHER brands for the food service, hospitality, convenience store, and health care markets. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

What sector is Nephros in?

Nephros is in the Healthcare sector

What industry is Nephros in?

Nephros is in the Medical Instruments & Supplies industry

What country is Nephros from?

Nephros is headquartered in United States

When did Nephros go public?

Nephros initial public offering (IPO) was on 21 September 2004

What is Nephros website?

https://www.nephros.com

Is Nephros in the S&P 500?

No, Nephros is not included in the S&P 500 index

Is Nephros in the NASDAQ 100?

No, Nephros is not included in the NASDAQ 100 index

Is Nephros in the Dow Jones?

No, Nephros is not included in the Dow Jones index

When does Nephros report earnings?

The next expected earnings date for Nephros is 30 August 2024